ScieGen Pharmaceuticals, Inc recalls WP Westminster, more — Irbesartan Tablets, USP 75 mg, 150 mg, and 300 mg dosage forms
- Recall date
- May 3, 2019
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- ScieGen Pharmaceuticals, Inc, WP Westminster, more
Why it was recalled
Due to detection of NDEA (N-Nitrosodiethylamine) Impurity — Potential Lack of Sterility
What was recalled
Irbesartan Tablets, USP 75 mg, 150 mg, and 300 mg dosage forms
Read the official recall notice →
Get recall alerts
Free email alert whenever ScieGen Pharmaceuticals, Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: ScieGen Pharmaceuticals, Inc, WP Westminster, more